Hillsdale Investment Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-100,200
| Closed | -$3.24M | – | 632 |
|
|
2024
Q1 | $3.24M | Buy |
100,200
+8,200
| +9% | +$265K | 0.26% | 159 |
|
|
2023
Q4 | $3.88M | Sell |
92,000
-24,300
| -21% | -$1.02M | 0.32% | 120 |
|
|
2023
Q3 | $4.46M | Sell |
116,300
-21,800
| -16% | -$837K | 0.41% | 68 |
|
|
2023
Q2 | $2.62M | Sell |
138,100
-124,000
| -47% | -$2.35M | 0.24% | 151 |
|
|
2023
Q1 | $4.07M | Buy |
+262,100
| New | +$4.07M | 0.35% | 107 |
|